Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/23
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 10/28/22
End: 10/31/23
Due: 10/31/24
Phase: N/A
Priority: Normal
Start: 07/01/22
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 06/01/23
End: 12/31/25
Due: 12/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| GNB4 and Riplet Gene Methylation Combined Detection Kit (Fluorescence PCR Method) | NCT05668793 | Wuhan Ammunition Life-tech Co., Ltd | user2@example.com | None | 2023-01-31 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |
| KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method) | NCT05680077 | Wuhan Ammunition Life-tech Co., Ltd | user2@example.com | None | 2022-10-28 | 2023-10-31 | 2024-10-31 | - | - | 2025-07-14 |
| Clinical Study of Pan-cancer DNA Methylation Test in Plasma | NCT05685524 | Wuhan Ammunition Life-tech Co., Ltd | user2@example.com | None | 2022-07-01 | 2023-12-31 | 2024-12-31 | - | - | 2025-07-14 |
| The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma | NCT06564363 | Wuhan Ammunition Life-tech Co., Ltd | user2@example.com | None | 2023-06-01 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |